Exscientia 17. Dez. 2025 Recursion Pharmaceuticals Stock (RXRX) Opinions on Exscientia Merger and Clinical Data Readout - Quiver Quantitative
Exscientia 30. Okt. 2025 BMS removes 2 clinical programs from pipeline, one from Mirati and another from Exscientia - Fierce Biotech
Exscientia 26. Okt. 2025 Recursion Pharmaceuticals Stock (RXRX) Opinions on Exscientia Acquisition and Partnerships | RXRX Stock News - Quiver Quantitative
Exscientia 20. Okt. 2025 Recursion Pharmaceuticals (RXRX) Is Up 6.0% After New AI Partnerships and Exscientia Acquisition Has the Bull Case Changed? - Yahoo Finance
Exscientia 13. Okt. 2025 Exscientia Wins Dismissal of Investor Suit Over CEO Misconduct - Bloomberg Law News
Exscientia 28. Mai 2025 The first test of Recursion's Exscientia move | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline
Exscientia 2. Okt. 2024 Exscientia outline robot and AI use in drug discovery workflow - Clinical Trials Arena